BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 19394890)

  • 1. Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies.
    Rapisarda A; Melillo G
    Drug Resist Updat; 2009 Jun; 12(3):74-80. PubMed ID: 19394890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced tumor cell autophagy mediates resistance to anti-angiogenic therapy.
    Hu YL; Jahangiri A; De Lay M; Aghi MK
    Autophagy; 2012 Jun; 8(6):979-81. PubMed ID: 22714142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia.
    Rapisarda A; Melillo G
    Nat Rev Clin Oncol; 2012 Apr; 9(7):378-90. PubMed ID: 22525710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic strategies and agents in clinical trials.
    Rosen L
    Oncologist; 2000; 5 Suppl 1():20-7. PubMed ID: 10804087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour angiogenesis, anti-angiogenic therapy and chemotherapeutic resistance.
    Mander KA; Finnie JW
    Aust Vet J; 2018 Oct; 96(10):371-378. PubMed ID: 30255577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rationale of antiangiogenic therapy].
    Tímár J; Paku S; Tóvári J; Döme B
    Magy Onkol; 2006; 50(2):141-51. PubMed ID: 16888678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
    Sato Y
    Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vessel co-option and resistance to anti-angiogenic therapy.
    Kuczynski EA; Reynolds AR
    Angiogenesis; 2020 Feb; 23(1):55-74. PubMed ID: 31865479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
    Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modes of resistance to anti-angiogenic therapy.
    Bergers G; Hanahan D
    Nat Rev Cancer; 2008 Aug; 8(8):592-603. PubMed ID: 18650835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redundant angiogenic signaling and tumor drug resistance.
    Gacche RN; Assaraf YG
    Drug Resist Updat; 2018 Jan; 36():47-76. PubMed ID: 29499837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the tumor stroma in resistance to anti-angiogenic therapy.
    Huijbers EJ; van Beijnum JR; Thijssen VL; Sabrkhany S; Nowak-Sliwinska P; Griffioen AW
    Drug Resist Updat; 2016 Mar; 25():26-37. PubMed ID: 27155374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy as a mechanism for anti-angiogenic therapy resistance.
    Chandra A; Rick J; Yagnik G; Aghi MK
    Semin Cancer Biol; 2020 Nov; 66():75-88. PubMed ID: 31472232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality.
    McIntyre A; Harris AL
    EMBO Mol Med; 2015 Apr; 7(4):368-79. PubMed ID: 25700172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance to anti-angiogenic therapy: a clinical and scientific current issue].
    Gu Y; Lu H; Boisson-Vidal C; Li H; Bousquet G; Janin A; Di Benedetto M
    Med Sci (Paris); 2016 Apr; 32(4):370-7. PubMed ID: 27137694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor angiogenesis: recent progress and remaining challenges].
    Feige JJ
    Bull Cancer; 2010 Nov; 97(11):1305-10. PubMed ID: 21051315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic therapies in cancer: achievements and open questions.
    Ruegg C; Mutter N
    Bull Cancer; 2007 Sep; 94(9):753-62. PubMed ID: 17878094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic therapy: a novel approach to overcome tumor hypoxia.
    Peng F; Chen M
    Chin J Cancer; 2010 Aug; 29(8):715-20. PubMed ID: 20663317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiogenic process as a therapeutic target in cancer.
    Bridges EM; Harris AL
    Biochem Pharmacol; 2011 May; 81(10):1183-91. PubMed ID: 21382350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.